Trial Profile
Docetaxol combined with S1 treatment for locally adanced and/or metastatic breast cancer patients' clinical trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 06 Jun 2012 New trial record